PI
KLRS

Pennant Investors’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Pennant Investors’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-9,378
Closed -$156K – 45
2024
Q2 		$156K Hold
9,378
– – 0.04% 41
2024
Q1 		$163K Hold
9,378
– – 0.04% 40
2023
Q4 		$147K Buy
+9,378
New +$147K 0.03% 39